Canadian LP giant Tilray has announced its involvement in a new Australian pilot study that explores the viability of a large-scale, placebo-controlled, randomized clinical trial of the use of a cannabis-derived compound for the treatment of aggressive behavioural problems in children with Intellectual Disabilities. Read More